Vet Pathol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gama, A.
Right arrow Articles by Schmitt, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gama, A.
Right arrow Articles by Schmitt, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Vet Pathol 40:412-420 (2003)
© 2003 American College of Veterinary Pathologists

p63: A Novel Myoepithelial Cell Marker in Canine Mammary Tissues

A. Gama, A. Alves, F. Gartner and F. Schmitt

Department of Pathology and Veterinary Clinics of the University of Trás os Montes e Alto Douro, Vila Real, Portugal (AG, AA); Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal (FG, FS); Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal (FG); and Medical Faculty, University of Porto, Porto, Portugal (FS)

Several immunohistochemical markers have been used to demonstrate the presence of myoepithelial cells in order to determine their role in the histogenesis of mammary tumors. p63, a recently characterized p53 homologue, is consistently expressed in myoepithelial cells of the human breast; however, no assessment of its immunoreactivity has been reported so far in canine mammary tissues. We investigated p63 immunohistochemical expression, as a novel myoepithelial cell nuclear marker, in 81 samples of normal (n = 2), hyperplastic (n = 11), and neoplastic (n = 68) canine mammary tissues. Myoepithelial phenotype was confirmed by using complementary monoclonal antibodies: alpha-smooth muscle actin, cytokeratin 14, cytokeratin AE1/AE3, and vimentin. p63 expression was observed in 91.4% (74/81) of the samples evaluated. Normal mammary glands, mammary hyperplasias, and benign tumors showed 100% immunoreactivity, with p63 expression restricted to myoepithelial cell nuclei. In general, benign mixed tumors showed a basal cell compartment immunoreactive to p63, with a gradual decrease of its expression during myoepithelial transformation. p63 expression was found in 72% of malignant tumors, allowing myoepithelial or basal cell identification in spindle-cell carcinomas (2/2), tubulopapillary carcinomas (8/9), solid carcinomas (7/10), and carcinosarcomas (1/3). The osteosarcoma analyzed was p63 negative. In our series, stromal components were consistently nonreactive to p63. In conclusion, the present study reveals p63 as a sensitive and highly specific marker of myoepithelial cells in canine mammary tissues, and the authors suggest p63 as an additional marker for defining myoepithelial histogenesis.


Key words: Dogs; immunohistochemistry; mammary gland; myoepithelial cell; p63.

Request reprints from Dr. F. Schmitt, IPATIMUP, R. Roberto Frias, S/N, 4200 Porto (Portugal). E-mail: fernando.schmitt{at}ipatimup.pt.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Vet PatholHome page
A. C. Bertagnolli, G. D. Cassali, M. C. L. S. Genelhu, F. A. Costa, J. F. C. Oliveira, and P. B. D. GonCalves
Immunohistochemical Expression of p63 and {Delta}Np63 in Mixed Tumors of Canine Mammary Glands and Its Relation with p53 Expression
Vet. Pathol., May 1, 2009; 46(3): 407 - 415.
[Abstract] [Full Text] [PDF]


Home page
jvdiHome page
G. D. Cassali, A. C. Bertagnolli, E. Ferreira, and M. C.C. Malta
A simple ductal mammary papilloma in a male maned wolf (Chrysocyon brachyurus)
J Vet Diagn Invest, January 1, 2009; 21(1): 153 - 155.
[Abstract] [Full Text] [PDF]


Home page
jvdiHome page
F. Sassi, G. Sarli, B. Brunetti, F. Morandi, and C. Benazzi
Immunohistochemical characterization of mammary squamous cell carcinoma of the dog
J Vet Diagn Invest, November 1, 2008; 20(6): 766 - 773.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
H. Wensman, V. Flama, G. Pejler, and E. Hellmen
Plasticity of Cloned Canine Mammary Spindle Cell Tumor, Osteosarcoma and Carcinoma Cells
Vet. Pathol., November 1, 2008; 45(6): 803 - 815.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
K. A. Maratea, J. A. Ramos-Vara, L. A. Corriveau, and M. A. Miller
Testicular Interstitial Cell Tumor and Gynecomastia in a Rabbit
Vet. Pathol., July 1, 2007; 44(4): 513 - 517.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
L. N. Z. Ramalho, A. Ribeiro-Silva, G. D. Cassali, and S. Zucoloto
The Expression of p63 and Cytokeratin 5 in Mixed Tumors of the Canine Mammary Gland Provides New Insights into the Histogenesis of These Neoplasms.
Vet. Pathol., July 1, 2006; 43(4): 424 - 429.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Veterinary Pathologists.